Zobrazeno 1 - 10
of 38
pro vyhledávání: '"A M, Hoos"'
Autor:
Gregory M. Ruiz, Phillip M. Hoos, Robert C. Vrijenhoek, A. Whitman Miller, Jonathan B. Geller
Publikováno v:
Diversity and Distributions. 16:582-592
Aim Historical information about source populations of invasive species is often limited; therefore, genetic analyses are used. We compared inference about source populations from historical and genetic data for the oyster-associated clam, Gemma gemm
Autor:
Galya Vassileva, Lizbeth M. Hoos, Glen Tetzloff, Eric L. Gustafson, Harry R. Davis, Li Liu, Ling Kang, Shijun Yang, Joseph A. Hedrick, Hong Lan, Timothy J. Kowalski, Weiwen Hu
Publikováno v:
Journal of Endocrinology. 205:225-232
G-protein-coupled bile acid receptor 1 (GPBAR1/TGR5/M-Bar/GPR131) is a cell surface receptor involved in the regulation of bile acid metabolism. We have previously shown that Gpbar1-null mice are resistant to cholesterol gallstone disease when fed a
Autor:
Glen Tetzloff, Harry R. Davis, Sean M. Lally, Lizbeth M. Hoos, Federica Basso, Scott W. Altmann
Publikováno v:
Atherosclerosis Supplements. 9:77-81
Ezetimibe is a selective cholesterol absorption inhibitor, which potently inhibits the uptake and absorption of biliary and dietary cholesterol from the small intestine without affecting the absorption of fat-soluble vitamins, triglycerides or bile a
Publikováno v:
Patient Education and Counseling. 60:24-31
Objective Using standardized video cases in a computerized objective structured video examination (OSVE) aims to measure cognitive scripts underlying overt communication behavior by questions on knowledge, understanding and performance. In this study
Autor:
Patricia A. Detmers, Scott W. Altmann, Glen Tetzloff, Sai Prasad N Iyer, Xiaorui Yao, Michael P. Graziano, Erik G. Lund, My-Hanh Lam, Harry R. Davis, Maureen Maguire, Li-ji Zhu, Lizbeth M. Hoos, Jianjun Liu
Publikováno v:
Journal of Biological Chemistry. 279:33586-33592
Niemann-Pick C1 Like 1 (NPC1L1) is a protein localized in jejunal enterocytes that is critical for intestinal cholesterol absorption. The uptake of intestinal phytosterols and cholesterol into absorptive enterocytes in the intestine is not fully defi
Autor:
Glen Tetzloff, Xiaorui Yao, Lizbeth M. Hoos, Scott W. Altmann, Harry R. Davis, Ming Zeng, Michael P. Graziano, Luquan Wang, Li-ji Zhu, Sai Prasad N. Iyer, Andrei Golovko, Nicholas J. Murgolo, Maureen Maguire
Publikováno v:
Science. 303:1201-1204
Dietary cholesterol consumption and intestinal cholesterol absorption contribute to plasma cholesterol levels, a risk factor for coronary heart disease. The molecular mechanism of sterol uptake from the lumen of the small intestine is poorly defined.
Autor:
Douglas S Compton, Harry R. Davis, Lizbeth M. Hoos, April Smith-Torhan, Margaret van Heek, Constance Farley
Publikováno v:
British Journal of Pharmacology. 138:1459-1464
Ezetimibe (1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone) and its analog SCH48461 are potent and selective cholesterol absorption inhibitors that inhibit the transport of cholesterol across the i
Autor:
Lizbeth M. Hoos, Laura Sepp-Lorenzino, Walter Strapps, John Levorse, Dietmar Seiffert, Karen R. Leander, Marti DiPietro, Yuchen Zhou, Anil Thankappan, Weizhen Wu, Tian-Quan Cai, Zuo Zhang, Zhu Chen, Yiming Xu, Marija Tadin-Strapps, Myung K. Shin, Patrick Andre, Joseph M. Metzger, Kunal Desai, KehDih Lai, Nina Jochnowitz, Ross Bentley
Publikováno v:
Thrombosis and haemostasis. 113(6)
SummaryHaemophilia A and B are characterised by a life-long bleeding predisposition, and several lines of evidence suggest that risks of atherothrombotic events may also be reduced. Establishing a direct correlation between coagulation factor levels,
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 21:2032-2038
Ezetimibe (SCH58235) is a potent, selective, cholesterol absorption inhibitor. The objective of this study was to determine whether ezetimibe reduces plasma cholesterol and inhibits atherogenesis in apolipoprotein E knockout (apoE−/−) mice. Chole
Publikováno v:
British Journal of Pharmacology. 134:409-417
1. Ezetimibe potently inhibits the transport of cholesterol across the intestinal wall, thereby reducing plasma cholesterol in preclinical animal models of hypercholesterolemia. The effect of ezetimibe on known absorptive processes was determined in